Nuclear AhR and membranous PD-L1 in predicting response of non-small cell lung cancer to PD-1 blockade

• Si-Chong Han,
• Gui-Zhen Wang,
• Ya-Ning Yang,
• Wen-Feng Fang,
• Bei-Bei Sun,
• Jian-Dong Zhang,
• Hua-Qiang Zhou,
• Li Zhang,
• Yan Wang,
• Guang-Biao Zhou

Affiliations

Si-Chong Han

State Key Laboratory of Molecular Oncology and Department of Internal Medicine, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College

Gui-Zhen Wang

State Key Laboratory of Molecular Oncology and Department of Internal Medicine, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College

Ya-Ning Yang

State Key Laboratory of Molecular Oncology and Department of Internal Medicine, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College

Wen-Feng Fang

Lung Cancer Research Centre and State Key Laboratory of Oncology in South China, Sun Yat-Sen University Cancer Center

Bei-Bei Sun

State Key Laboratory of Molecular Oncology and Department of Internal Medicine, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College

Jian-Dong Zhang

Shanxi Bethune Hospital Affiliated with Shanxi Academy of Medical Sciences

Hua-Qiang Zhou

Lung Cancer Research Centre and State Key Laboratory of Oncology in South China, Sun Yat-Sen University Cancer Center

Li Zhang

Lung Cancer Research Centre and State Key Laboratory of Oncology in South China, Sun Yat-Sen University Cancer Center

Yan Wang

State Key Laboratory of Molecular Oncology and Department of Internal Medicine, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College

Guang-Biao Zhou

State Key Laboratory of Molecular Oncology and Department of Internal Medicine, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College